SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
AUTOR(ES)
Bennett, Brydon L.
FONTE
The National Academy of Sciences
RESUMO
Jun N-terminal kinase (JNK) is a stress-activated protein kinase that can be induced by inflammatory cytokines, bacterial endotoxin, osmotic shock, UV radiation, and hypoxia. We report the identification of an anthrapyrazolone series with significant inhibition of JNK1, -2, and -3 (Ki = 0.19 μM). SP600125 is a reversible ATP-competitive inhibitor with >20-fold selectivity vs. a range of kinases and enzymes tested. In cells, SP600125 dose dependently inhibited the phosphorylation of c-Jun, the expression of inflammatory genes COX-2, IL-2, IFN-γ, TNF-α, and prevented the activation and differentiation of primary human CD4 cell cultures. In animal studies, SP600125 blocked (bacterial) lipopolysaccharide-induced expression of tumor necrosis factor-α and inhibited anti-CD3-induced apoptosis of CD4+ CD8+ thymocytes. Our study supports targeting JNK as an important strategy in inflammatory disease, apoptotic cell death, and cancer.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=61101Documentos Relacionados
- Complexes of p21RAS with JUN N-terminal kinase and JUN proteins.
- Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase.
- Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages.
- Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase
- The MLK Family Mediates c-Jun N-Terminal Kinase Activation in Neuronal Apoptosis
